Park Avenue Securities LLC Exact Sciences Corp Transaction History

Park Avenue Securities LLC

$8.9 Billion
Q3 2024

A detailed history of Park Avenue Securities LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Park Avenue Securities LLC holds 25,317 shares of EXAS stock, worth $1.79 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

25,317

Previous 32,527 22.17%

Holding current value

$1.79 Million

Previous $1.37 Million 25.55%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$42.43 - $70.83 $305,920 - $510,684	-7,210 Reduced 22.17%	25,317 $1.73 Million
Q2 2024 Jul 09, 2024	BUY	$41.33 - $74.26 $170,568 - $306,471	4,127 Added 14.53%	32,527 $1.37 Million
Q1 2024 Apr 10, 2024	BUY	$56.27 - $73.77 $402,386 - $527,529	7,151 Added 33.65%	28,400 $1.96 Million
Q4 2023 Jan 10, 2024	SELL	$59.06 - $75.72 $118 - $151	-2 Reduced 0.01%	21,249 $1.57 Million
Q3 2023 Oct 26, 2023	SELL	$65.94 - $99.04 $198,809 - $298,605	-3,015 Reduced 12.42%	21,251 $1.45 Million
Q2 2023 Jul 14, 2023	SELL	$62.68 - $95.05 $92,766 - $140,674	-1,480 Reduced 5.75%	24,266 $2.28 Million
Q1 2023 Apr 18, 2023	SELL	$47.19 - $70.77 $175,641 - $263,405	-3,722 Reduced 12.63%	25,746 $1.75 Million
Q4 2022 Jan 24, 2023	BUY	$30.35 - $53.15 $115,967 - $203,086	3,821 Added 14.9%	29,468 $0
Q3 2022 Nov 01, 2022	SELL	$31.97 - $49.37 $65,570 - $101,257	-2,051 Reduced 7.4%	25,647 $833,000
Q2 2022 Jul 27, 2022	BUY	$35.61 - $76.23 $79,908 - $171,060	2,244 Added 8.82%	27,698 $1.09 Million
Q1 2022 Apr 29, 2022	BUY	$57.56 - $82.54 $407,582 - $584,465	7,081 Added 38.54%	25,454 $1.78 Million
Q4 2021 Apr 08, 2022	BUY	$72.5 - $100.68 $132,167 - $183,539	1,823 Added 11.02%	18,373 $1.43 Million
Q3 2021 Oct 21, 2021	BUY	$90.24 - $124.05 $158,100 - $217,335	1,752 Added 11.84%	16,550 $1.58 Million
Q2 2021 Aug 05, 2021	BUY	$93.66 - $139.27 $294,467 - $437,864	3,144 Added 26.98%	14,798 $1.84 Million
Q1 2021 Apr 28, 2021	BUY	$116.57 - $155.01 $607,679 - $808,067	5,213 Added 80.93%	11,654 $1.54 Million
Q4 2020 Jan 20, 2021	BUY	$99.61 - $142.12 $381,705 - $544,603	3,832 Added 146.88%	6,441 $853,000
Q3 2020 Nov 03, 2020	BUY	$72.92 - $102.01 $190,248 - $266,144	2,609 New	2,609 $266,000

Others Institutions Holding EXAS

# of Institutions

617

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Exact Sciences Corp Transaction History